NCT00475800View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

PHASE3CompletedINTERVENTIONAL

Enrollment

833

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2004

Conditions

Osteoarthritis

Interventions

DRUG

Lumiracoxib

Trial Locations (6)

55430

Brooklyn Park

57105

Sioux Falls

78232

San Antonio

85723

Tucson

87109

Albuquerque

Unknown

Novartis Investigative Site, Brampton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY